Rennova Health Inc (RNVA)

[nfrequent]

2023 year over year: 75% increase in (CAH reimbursable) inpatient admissions. 4% increase in ER services to patients who no longer have to be transferred to a Knoxville hospital (thanks to CAH). 8% increase in outpatient services with a many times greater increase to come in 2024 from the new Myrtle Recovery Center outpatient operation. Over $2 million added to the 2024 bottom line in interest savings on debt paid off and restructured in 2023. More restructuring of debt "and other securities" ongoing. Add all that to the 2022 annual report, then subtract the first 9 months results from 2023, and you get Q4 revenue and earnings growth soaring off the chart. All this thing needs is one large investor who actually does their DD to search out the best pink sheet bargain on the board. RNVA is the no brainer of 2024.